Search filters

List of works by Mark Hickman

Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major Amastigotes

scientific article

Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections

scientific article published on 14 April 2014

Detection of influenza virus from throat and pharyngeal swabs with a nested duplex light cycler RT-PCR.

scientific article published in May 2003

Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis

scientific article (publication date: September 2014)

Field evaluation of diagnostic performance of malaria rapid diagnostic tests in western Kenya

scientific article published on 07 September 2016

Formulation and particle size reduction improve bioavailability of poorly water-soluble compounds with antimalarial activity

scientific article published on 12 May 2013

Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii

scientific article published on 14 June 2013

Modulating Acinetobacter baumannii biofilm development with molecules containing 3,4,5-trimethoxy-N,N',N'-trimethylbenzohydrazide moiety.

scientific article

Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage Plasmodium infections in mice

scientific article published on July 25, 2013

Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study

scientific article

Pre-clinical evaluation of CYP 2D6 dependent drug-drug interactions between primaquine and SSRI/SNRI antidepressants

scientific article published on 17 May 2016

Salicylanilide Inhibitors of Toxoplasma gondii

scientific article published on September 26, 2012

Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds.

scientific article published on 03 January 2014

Toxicokinetic and toxicodynamic (TK/TD) evaluation to determine and predict the neurotoxicity of artemisinins

scientific article